A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)
NCT00780585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95
Last updated 2014-12-19
Summary
This is a safety study evaluating the subjects who participated in previous Organon trials of the drug Org 24448. Patients will undergo a Screening visit, 1 or 2 Evaluation visits, and a possible Follow-Up period. During the visits, study tests, including echocardiograms, will be performed to summarize cardiac functioning.
Conditions
Interventions
- DRUG
-
SCH 900460
Subjects who participated in previous trials of Org 24448 (SCH 900460)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2009-01-31
- Completion
- 2009-01-31
More Related Trials
-
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
NCT00425815 ·Status: WITHDRAWN ·Phase: PHASE2
-
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
NCT01760889 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
NCT04109950 ·Status: TERMINATED ·Phase: PHASE3
-
Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia
NCT02332798 ·Status: COMPLETED ·Phase: PHASE1
-
Short Term Rescue Study of Olanzapine
NCT00186017 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic
NCT02007928 ·Status: COMPLETED ·Phase: NA
-
Safety Study of ORG 34517 for Major Depression With Psychotic Features
NCT00226278 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT04072354 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
NCT00480571 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults
NCT01429740 ·Status: COMPLETED ·Phase: PHASE1
-
Cardio Risk of Acute Schizophrenia Olanzapine Duke
NCT00672464 ·Status: WITHDRAWN ·Phase: PHASE4
-
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
NCT02504476 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia
NCT01829048 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
NCT02969382 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter, Open-label, Safety and Tolerability Study
NCT01649557 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
NCT06179108 ·Status: COMPLETED ·Phase: PHASE2
-
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
NCT00595504 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
NCT00734435 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability Study of Drug to Treat Schizophrenia
NCT00044005 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
NCT00454883 ·Status: COMPLETED
-
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)
NCT00281320 ·Status: COMPLETED ·Phase: PHASE3
-
Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder
NCT00050206 ·Status: COMPLETED ·Phase: PHASE4
-
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
NCT00051298 ·Status: COMPLETED ·Phase: PHASE3
-
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
NCT03351244 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1 Safety Study in Adults With Schizophrenia
NCT02804568 ·Status: COMPLETED ·Phase: PHASE1